Skip to main content Accessibility help
Hostname: page-component-dc8c957cd-mgc9c Total loading time: 4.91 Render date: 2022-01-28T20:44:26.882Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Book contents

Chapter 56 - Threatened and Actual Preterm Labor (Content last reviewed: 14th December 2020)

from Section 6 - Late Prenatal – Obstetric Problems

Published online by Cambridge University Press:  15 November 2017

David James
University of Nottingham
Philip Steer
Imperial College London
Carl Weiner
University of Kansas
Bernard Gonik
Wayne State University, Detroit
Stephen Robson
University of Newcastle
Get access


Despite the long-term focus on its prevention, preterm birth remains the leading cause of neonatal death, and the second leading cause of under-5 mortality, after pneumonia, worldwide. Of those babies who survive, many have severe long-term physical and neurodevelopmental morbidity. Management options for pregnant women with threatened preterm birth focus on delaying delivery using tocolysis, and administering antenatal therapy such as corticosteroids and, more recently, magnesium sulfate (for fetal lung development and neuroprotection respectively) to improve outcome for the infant once born. Given that most women who present with preterm contractions do not go on to deliver preterm infants, the challenge is to identify the appropriate recipients of these therapies.

High-Risk Pregnancy
Management Options
, pp. 1623 - 1653
Publisher: Cambridge University Press
First published in: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)


World Health Organization. WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand 1977; 56: 247–53.
Steer, P. The epidemiology of preterm labour. BJOG 2005; 112 (s1): 13.
Blencowe, H, Cousens, S, Chou, D, et al. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health 2013; 10 (Suppl 1): S2.
Marlow, N Full term: an artificial concept. Arch Dis Child Fetal Neonatal Ed 2012; 97: F158–9.
Goldenberg, RL, Culhane, JF, Iams, JD, Romero, R. Epidemiology and causes of preterm birth. Lancet 2008; 371: 7584.
Blencowe, H, Cousens, S, Oestergaard, MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012; 379: 2162–72.
Lawn, J, Kerber, K, Enweronu-Laryea, C, Cousens, S. 3.6 million neonatal deaths: what is progressing and what is not? Semin Perinatol 2010; 34: 371–86.
Winkvist, A, Mogren, I, Högberg, U. Familial patterns in birth characteristics: impact on individual and population risks. Int J Epidemiol 1998; 27: 248–54.
Shah, PS, Shah, V. Influence of the maternal birth status on offspring: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2009; 88: 1307–18. doi: 10.3109/00016340903358820.
Strauss, JF, Romero, R, Gomez-Lopez, N, et al. Spontaneous preterm birth: advances toward the discovery of genetic predisposition. Am J Obstet Gynecol 2018; 218: 294314.e2. doi: 10.1016/j.ajog.2017.12.009.
Smid, MC, Lee, JH, Grant, JH, et al. Maternal race and intergenerational preterm birth recurrence. Am J Obstet Gynecol 2017; 217: 480.e1–9. doi: 10.1016/j.ajog.2017.05.051.
Esplin, MS, Manuck, TA, Varner, MW, et al. Cluster analysis of spontaneous preterm birth phenotypes identifies potential associations among preterm birth mechanisms. Am J Obstet Gynecol 2015; 213: 429.e1–9. doi: 10.1016/j.ajog.2015.06.011.
Menon, R, Velez, DR, Thorsen, P, et al. Ethnic differences in key candidate genes for spontaneous preterm birth: TNF-alpha and its receptors. Hum Hered 2006; 62: 107–18.
Engel, SA, Erichsen, HC, Savitz, DA, et al. Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms. Epidemiology 2005; 16: 469–77.
Zhang, G, Feenstra, B, Bacelis, J, et al. Genetic associations with gestational duration and spontaneous preterm birth. N Engl J Med 2017; 377: 1156–67. doi: 10.1056/NEJMoa1612665.
Moore, T, Hennessy, EM, Myles, J, et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 2012; 345: e7961.
Costeloe, K, Hennessy, E, Gibson, AT, Marlow, N, Wilkinson, AR. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000; 106: 659–71.
Costeloe, KL, Hennessy, EM, Haider, S, et al. Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ 2012; 345: e7976.
Wood, N, Costeloe, K, Gibson, A, et al. The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed 2005; 90: F134–40.
Mangham, LJ, Petrou, S, Doyle, LW, Draper, ES, Marlow, N. The cost of preterm birth throughout childhood in England and Wales. Pediatrics 2009; 123: e312–27.
Butler, AS, Behrman, RE. Preterm Birth: Causes, Consequences, and Prevention. Washington, DC: National Academies Press, 2007.
Goldenberg, RL, Iams, JD, Mercer, BM, et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health 1998; 88: 233–8.
Mercer, BM, Goldenberg, RL, Moawad, AH, et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. Am J Obstet Gynecol 1999; 181: 1216–21.
McManemy, J, Cooke, E, Amon, E, Leet, T Recurrence risk for preterm delivery. Am J Obstet Gynecol 2007; 196: 576.e1–6.
Crane, JM, Delaney, T, Hutchens, D. Transvaginal ultrasonography in the prediction of preterm birth after treatment for cervical intraepithelial neoplasia. Obstet Gynecol 2006; 107: 3744.
Castanon, A, Brocklehurst, P, Evans, H, et al. Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective–prospective cohort study. BMJ 2012; 345: e5174.
Levine, LD, Sammel, MD, Hirshberg, A, Elovitz, MA, Srinivas, SK. Does stage of labor at time of cesarean delivery affect risk of subsequent preterm birth? Am J Obstet Gynecol 2015; 212: 360.e17. doi: 10.1016/j.ajog.2014.09.035.
Watson, HA, Ridout, A, Shennan, AH. Second stage cesarean as risk factor for preterm birth: how to manage subsequent pregnancies? Am J Obstet Gynecol 2018; 218: 367–8. doi: 10.1016/j.ajog.2017.11.589.
Hickland MM, Story L, Glazewska-Hallin A, et al. Efficacy of transvaginal cervical cerclage in women at risk of preterm birth following previous emergency cesarean section. Acta Obstet Gynecol Scand 2020; 99: 1486–91.
Meis, PJ, Goldenberg, RL, Mercer, BM, et al. The preterm prediction study: risk factors for indicated preterm births. Am J Obstet Gynecol 1998; 178: 562–7.
Homer, HA, Li, TC, Cooke, ID. The septate uterus: a review of management and reproductive outcome. Fertil Steril 2000; 73: 114.
Tomaževič, T, Ban-Frangež, H, Ribič-Pucelj, M, Premru-Sršen, T, Verdenik, I. Small uterine septum is an important risk variable for preterm birth. Eur J Obstet Gynecol Reprod Biol 2007; 135: 154–7.
Da Silva, AA, Simões, VM, Barbieri, MA, et al. Young maternal age and preterm birth. Paediatr Perinat Epidemiol 2003; 17: 332–9.
Brett, K, Strogatz, D, Savitz, D. Employment, job strain, and preterm delivery among women in North Carolina. Am J Public Health 1997; 87: 199204.
Smith, LK, Draper, ES, Manktelow, BN, Doring, JS, Field, JA. Socioeconomic inequalities in very preterm birth rates. Arch Dis Child Fetal Neonatal Ed 2007; 92: F11–14.
Hendler, I, Goldenberg, RL, Mercer, BM, et al. The Preterm Prediction Study: association between maternal body mass index and spontaneous and indicated preterm birth. Am J Obstet Gynecol 2005; 192: 882–6.
Reagan, PB, Salsberry, PJ. Race and ethnic differences in determinants of preterm birth in the USA: broadening the social context. Soc Sci Med 2005; 60: 2217–28.
Simhan, HN, Bodnar, LM. Pre-pregnancy body mass index, vaginal inflammation, and the racial disparity in preterm birth. Am J Epidemiol 2006; 163: 459–66.
Zhang, J, Savitz, DA. Preterm birth subtypes among blacks and whites. Epidemiology 1992; 3: 428–33.
Balchin, I, Steer, PJ. Race, prematurity and immaturity. Early Hum Dev 2007; 83: 749–54.
Menon, R, Fortunato, SJ, Edwards, DR, Williams, SM. Association of genetic variants, ethnicity and preterm birth with amniotic fluid cytokine concentrations. Ann Hum Genet 2010; 74: 165–83.
Creasy, RK, Gummer, BA, Liggins, GC. System for predicting spontaneous preterm birth. Obstet Gynecol 1980; 55: 692–5.
Honest, H, Bachmann, L, Sundaram, R, et al. The accuracy of risk scores in predicting preterm birth: a systematic review. J Obstet Gynecol 2004; 24: 343–59.
Hillier, SL, Witkin, SS, Krohn, MA, et al. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993; 81: 941–8.
Gomez, R, Ghezzi, F, Romero, R, et al. Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 1995; 22: 281342.
Greig, PC, Ernest, J, Teot, L, Erikkson, M, Talley, R. Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amniotic fluid cultures in patients in premature labor with intact membranes. Am J Obstet Gynecol 1993; 169: 1035–44.
Simhan, HN, Caritis, SN, Krohn, MA, et al. Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol 2003; 189: 560–7.
Wei, SQ, Fraser, W, Luo, ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol 2010; 116: 393401.
Abbott, DS, Chin-Smith, EC, Seed, PT, et al. Raised Trappin2/elafin protein in cervico-vaginal fluid is a potential predictor of cervical shortening and spontaneous preterm birth. PloS one 2014; 9: e100771.
Stock, SJ, Duthie, L, Tremaine, T, et al. Elafin (SKALP/Trappin-2/proteinase inhibitor-3) is produced by the cervix in pregnancy and cervicovaginal levels are diminished in bacterial vaginosis. Reprod Sci 2009; 16: 1125–34.
Espinoza, J, Chaiworapongsa, T, Romero, R, et al. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med 2003; 13: 221.
Rubens, CE, Sadovsky, Y, Muglia, L, et al. Prevention of preterm birth: harnessing science to address the global epidemic. Sci Transl Med 2014; 262: 262sr5.
Racicot, K, Cardenas, I, Wunsche, V, et al. Viral infection of the pregnant cervix predisposes to ascending bacterial infection. J Immunol 2013; 191: 934–41.
Kalanda, BF, Verhoeff, F, Chimsuku, L, Harper, G, Brabin, BJ. Adverse birth outcomes in a malarious area. Epidemiol Infect 2006; 134: 659–66.
Madinger, NE, Greenspoon, JS, Gray Ellrodt, A. Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? Am J Obstet Gynecol 1989; 161: 657–62.
Goodnight, WH, Soper, DE. Pneumonia in pregnancy. Crit Care Med 2005; 33: S390–7.
Romero, R, Oyarzun, E, Mazor, M, et al. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989; 73: 576–82.
Leitich, H, Bodner-Adler, B, Brunbauer, M, et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003; 189: 139–47.
Chandiramani, M, Seed, PT, Orsi, NM, et al. Limited relationship between cervico-vaginal fluid cytokine profiles and cervical shortening in women at high risk of spontaneous preterm birth. PloS one 2012; 7: e52412.
Hirsch, E, Saotome, I, Hirsch, D. A model of intrauterine infection and preterm delivery in mice. Am J Obstet Gynecol 1995; 172: 1598–603.
Gibbs, RS, McDuffie, RS, Kunze, M, et al. Experimental intrauterine infection with Prevotella bivia in New Zealand White rabbits. Am J Obstet Gynecol 2004; 190: 1082–6.
McDuffie, R, Sherman, MP, Gibbs, RS. Amniotic fluid tumor necrosis factor-α and interleukin-1 in a rabbit model of bacterially induced preterm pregnancy loss. Am J Obstet Gynecol 1992; 167: 1583–8.
Romero, R, Mazor, M, Wu, YK, et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988; 12: 262–79.
Fidel, P, Ghezzi, F, Romero, R, et al. The effect of antibiotic therapy on intrauterine infection-induced preterm parturition in rabbits. J Matern Fetal Neonatal Med 2003; 14: 5764.
Amsel, R, Totten, PA, Spiegel, CA, et al. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 1422.
Brocklehurst, P, Gordon, A, Heatley, E, Milan, SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2013; (1): CD000262.
Leitich, H, Kiss, H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007; 21: 375–90.
Vermeulen, GM, Bruinse, HW. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial. Br J Obstet Gynaecol 1999; 106: 652–7.
Shennan, A, Crawshaw, S, Briley, A, et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG 2006; 113: 6574.
Kurkinen-Räty, M, Vuopala, S, Koskela, M, et al. A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG 2000; 107: 1427–32.
Othman, M, Neilson, J, Alfirevic, Z. Probiotics for preventing preterm labour. Cochrane Database Syst Rev 2007; (1): CD005941.
Nicolle, LE, Bradley, S, Colgan, R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643–54.
Zalmanovici Trestioreanu, A, Lador, A, Sauerbrun-Cutler, MT, Leibovici, L, Antibiotics for asymptomatic bacteriuria. Cochrane Database Syst Rev 2015; (4): CD009534.
Meiss, PJ, Michielutte, R, Peters, T, et al. Factors associated with preterm birth in Cardiff, Wales: II. Indicated and spontaneous preterm birth. Am J Obstet Gynecol 1995; 173: 597602.
Villar, J, Gulmezoglu, AM, De Onis, M. Nutritional and antimicrobial interventions to prevent preterm birth: an overview of randomized controlled trials. Obstet Gynecol Surv 1998; 53: 575–85.
Smaill, FM, Vazquez, JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2007; (8): CD000490.
Heath, V, Southall, T, Souka, A, Novakov, A, Nikolaides, KH. Cervical length at 23 weeks of gestation: relation to demographic characteristics and previous obstetric history. Ultrasound Obst Gynecol 1998; 12: 304–11.
Iams, JD, Goldenberg, RL, Meis, PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. N Eng J Med 1996; 334: 567–73.
Onek, JD, Iams, J, Blumenfeld, M, et al. Measurement of cervical length in pregnancy: comparison between vaginal ultrasonography and digital examination. Obstet Gynecol 1990; 76: 172–5.
To, M, Skentou, C, Chan, C, Zagaliki, A, Nikolaides, KH. Cervical assessment at the routine 23-week scan: standardizing techniques. Ultrasound Obst Gynecol 2001; 17: 217–19.
Guzman, E, Walters, C, Ananth, C, et al. A comparison of sonographic cervical parameters in predicting spontaneous preterm birth in high-risk singleton gestations. Ultrasound Obst Gynecol 2001; 18: 204–10.
Owen, J, Yost, N, Berghella, V, et al. Midtrimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA 2001; 286: 1340–8.
Watson, WJ, Stevens, D, Welter, S, Day, D. Observations on the sonographic measurement of cervical length and the risk of premature birth. J Matern Fetal Med 1999; 8: 1719
Berghella, V, Tolosa, JE, Kuhlman, K, et al. Cervical ultrasonography compared with manual examination as a predictor of preterm delivery. Am J Obstet Gynecol 1997; 177: 723–30.
Andrews, WW, Copper, R, Hauth, JC, et al. Second-trimester cervical ultrasound: associations with increased risk for recurrent early spontaneous delivery. Obstet Gynecol 2000; 95: 222–6.
Cook, CM, Ellwood, D. The cervix as a predictor of preterm delivery in “at-risk” women. Ultrasound Obst Gynecol 2000; 15: 109–13.
Hassan, SS, Romero, R, Berry, SM, et al. Patients with an ultrasonographic cervical length ≤ 15 mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol 2000; 182: 1458–67.
Fuchs, I, Henrich, W, Osthues, K, Dudenhausen, JW. Sonographic cervical length in singleton pregnancies with intact membranes presenting with threatened preterm labor. Ultrasound Obst Gynecol 2004; 24: 554–7.
Sotiriadis, A, Papatheodorou, S, Kavvadias, A, Makrydimas, G. Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ultrasound Obst Gynecol 2010; 35: 5464.
Martin, JA, Hamilton, BE, Ventura, SJ, et al. Births: final data for 2011. Natl Vital Stat Rep 2013; 62: 190.
Lim, AC, Hegeman, MA, Huis In ‘T Veld, MA, et al. Cervical length measurement for the prediction of preterm birth in multiple pregnancies: a systematic review and bivariate meta-analysis. Ultrasound Obst Gynecol 2011; 38: 1017.
Fox, NS, Rebarber, A, Klauser, CK, et al. Prediction of spontaneous preterm birth in asymptomatic twin pregnancies using the change in cervical length over time. Am J Obstet Gynecol 2010; 202: 155.e1–4.
Hofmeister, C, Brizot, MdeL, Liao, A, Francisco, RP, Zugaib, M. Two-stage transvaginal cervical length screening for preterm birth in twin pregnancies. J Perinat Med 2010; 38: 479–84.
Oh, KJ, Park, KH, Jeong, EH, et al. The change in cervical length over time as a predictor of preterm delivery in asymptomatic women with twin pregnancies who have a normal mid-trimester cervical length. Twin Res Hum Genet 2012; 15: 516–21.
Khalil, MI, Alzahrani, MH, Ullah, A. The use of cervical length and change in cervical length for prediction of spontaneous preterm birth in asymptomatic twin pregnancies. Eur J Obstet Gynecol Reprod Biol 2013; 169: 193–6.
Conde-Agudelo, A, Romero, R. Prediction of preterm birth in twin gestations using biophysical and biochemical tests. Am J Obstet Gynecol 2014; 211: 583–95.
McLaren, JS, Hezelgrave, NL, Ayubi, H, Seed, P, Shennan, AH. Prediction of spontaneous preterm birth using quantitative fetal fibronectin after recent sexual intercourse. Am J Obstet Gynecol 2015; 212: 89.e1–5.
Hezelgrave, NL, Kuhrt, K, Cottam, K, et al. The effect of blood staining on cervicovaginal quantitative fetal fibronectin concentration and prediction of spontaneous preterm birth. Eur J Obstet Gynecol Reprod Biol 2017; 208: 103–8.
Lockwood, CJ, Senyei, AE, Dische, MR, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991; 325: 669–74
Shennan, AH, Jones, G, Haken, J, et al. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety. BJOG 2005; 112: 293–8.
Goepfert, AR, Goldenberg, RL, Mercer, B, et al. The Preterm Prediction Study: Quantitative fetal fibronectin values and the prediction of spontaneous preterm birth. Am J Obstet Gynecol 2000; 183: 1480–3.
Honest, H, Bachmann, LM, Gupta, JK, Kleijnen, J, Khan, KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 2002; 325: 301.
Iams, JD, Casal, D, McGregor, JA, et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995; 173: 141–5.
Abbott, DA, Hezelgrave, NL, Seed, PT, et al. Quantitative fetal fibronectin to predict preterm Birth in asymptomatic women at high risk. Obstet Gynecol 2015; 125: 1168–76.
Abbott, DS, Radford, SK, Seed, PT, Tribe, RM, Shennan, AH. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. Am J Obstet Gynecol 2013; 208: 122.e1–6.
DeFranco, EA, Lewis, DF, Odibo, AO. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am J Obstet Gynecol 2013; 208: 233.e1–6.
Kuhrt K, Hezelgrave-Elliott N, Stock SJ, et al. Quantitative fetal fibronectin for prediction of preterm birth in asymptomatic twin pregnancy. Acta Obstet Gynecol Scand 2020; 99: 1191–7.
Watson, HA, Seed, PT, Carter, J, et al. Development and validation of the predictive models for the QUiPP App v.2: a tool for predicting preterm birth in high-risk asymptomatic women. Ultrasound Obstet Gynecol 2019 Jul 20. doi: 10.1002/uog.20401.
Carter, J, Seed, PT, Watson, HA, et al. Development and validation of prediction models for the QUiPP App v.2: a tool for predicting preterm birth in women with symptoms of threatened preterm labor. Ultrasound Obstet Gynecol 2019 Aug 6. doi: 10.1002/uog.20422.
Goodfellow, L, Care, A, Sharp, A, et al. Effect of QUiPP prediction algorithm on treatment decisions in women with a previous preterm birth: a prospective cohort study. BJOG 2019; 126) :1569–75. doi: 10.1111/1471-0528.15886.
Petch, S, DeMaio, A, Daly, S. Prediction of recurrent preterm delivery in asymptomatic women: an anxiety reducing measure? Eur J Obstet Gynecol Reprod Biol X 2019; 4: 100064. doi: 10.1016/j.eurox.2019.100064.
Dawes, LK, Prentice, LR, Huang, Y, Groom, KM. The Biomarkers for Preterm Birth Study: a prospective observational study comparing the impact of vaginal biomarkers on clinical practice when used in women with symptoms of preterm labor. Acta Obstet Gynecol Scand 2020; 99: 249–58. doi: 10.1111/aogs.13729.
Akercan, F, Kazandi, M, Sendag, F, et al. Value of cervical phosphorylated insulin like growth factor binding protein-1 in the prediction of preterm labor. J Reprod Med 2004; 49: 368–72.
Honest, H, Hyde, CJ, Khan, KS. Prediction of spontaneous preterm birth: no good test for predicting a spontaneous preterm birth. Curr Opin Obstet Gynecol 2012; 24: 422–33.
Cooper, S, Lange, I, Wood, S, et al. Diagnostic accuracy of rapid phIGFBP-I assay for predicting preterm labor in symptomatic patients. J Perinatol 2011; 32: 460–5.
Petrunin, D, Griaznova, IM, Petrunina, I, Tatarinov, IuS. [Immunochemical identification of organ specific human placental alpha-1-globulin and its concentration in amniotic fluid]. Akush Ginekol (Mosk) 1977; 1: 62–4.
Nikolova, T, Bayev, O, Nikolova, N, Di Renzo, G. Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery. J Perinat Med 2014; 42: 473–7.
Macnaughton, M, Chalmers, I, Dubowitz, V, et al. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. Br J Obstet Gynaecol 1993; 100: 516–23.
National Institute for Health and Care Excellence. Preterm Labour and Birth. NICE Guideline NG25. London: NICE, 2015. (accessed March 2017).
To, MS, Alfirevic, Z, Heath, VC, et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet 2004; 363: 1849–53.
Berghella, V, Odibo, AO, To, MS, Rust, OA, Althusius, SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005; 106: 181–9.
Owen, J, Hankins, G, Iams, JD, et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol 2009; 201: 375.e1–8.
Althuisius, SM, Dekker, GA, Hummel, P, van Geijn, HP. Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2003; 189: 907–10.
Chandiramani, M, Shennan, AH. Premature cervical change and the use of cervical cerclage. Fetal Maternal Med Rev 2007; 18: 2552.
Odibo, AO, Berghella, V, To, MS, et al. Shirodkar versus McDonald cerclage for the prevention of preterm birth in women with short cervical length. Am J Perinatol 2007; 24: 5560.
Shennan, A, Chandiramani, M, Bennett, P, et al. MAVRIC: a multicentre randomised controlled trial of transabdominal versus transvaginal cervical cerclage. Am J Obstet Gynecol 2019 Oct 1. pii: S0002-9378(19)31206-2. doi: 10.1016/j.ajog.2019.09.040.
Dodd, JM, Jones, L, Flenady, V, Cincotta, R, Crowther, CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev 2013; (7): CD004947.
Meis, PJ, Klebanoff, M, Thom, E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379–85.
Keirse, MJ. Progesterone and preterm: seventy years of “deja vu” or “still to be seen”? Birth 2004; 31: 230–5.
Iams, JD, Newman, RB, Thom, EA, et al. Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Eng J Med 2002; 346: 250–5.
Romero, R, Yeo, L, Chaemsaithong, P, Chaiworapongsa, T, Hassan, SS. Progesterone to prevent spontaneous preterm birth. Semin Fetal Neonatal Med 2014; 19: 1526.
Romero, R, Nikolaides, K, Conde-Agudelo, A, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012; 206: 124.e1–19.
Grobman, WA, Thom, EA, Spong, CY, et al. 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol 2012; 207: 390.e1–8.
Durnwald, CP, Lynch, CD, Walker, H, Iams, JD. The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time. Am J Obstet Gynecol 2009; 201: 410.e1–5.
Norman, JE, Marlow, N, Messow, CM, et al. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet 2016; 387: 2106–16.
Romero, R, Nicolaides, KH, Conde-Agudelo, A, et al. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol 2016; 48: 308–17.
Patient-Centered Outcomes Research Institute. Evaluating hormone treatments for women at increased risk for preterm birth – EPPPIC. --epppic (accessed December 2020).
Briery, CM, Klauser, CK, Martin, RW, Magann, EF, Chauhan, SP, Morrison, JC The use of 17-hydroxy progesterone in women with arrested preterm labor: a randomized clinical trial. J Matern Fetal Neonatal Med 2014; 27: 1892–6.]
Martinez de Tejada, B, Karolinski, A, Ocampo, MC, et al. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. BJOG 2015; 122: 8091
Choudhary, M, Suneja, A, Vaid, NB, Guleria, K, Faridi, MM. Maintenance tocolysis with oral micronized progesterone for prevention of preterm birth after arrested preterm labor. Int J Gynaecol Obstet 2014; 126: 60–3.
Rode, L, Klein, K, Nicolaides, K, Krampl-Bettelheim, E, Tabor, A. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol 2011; 38: 272–80.
Norman, JE, Mackenzie, F, Owen, P, et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009; 373: 2034–40.
Wood, S, Ross, S, Tang, S, et al. Vaginal progesterone to prevent preterm birth in multiple pregnancy: a randomized controlled trial. J Perinat Med 2012; 40: 593–9.
Serra, V, Perales, A, Meseguer, J, et al. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial. BJOG 2013; 120: 50–7.
Conde-Agudelo, A, Romero, R, Hassan, SS, Yeo, L Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and metaanalysis. Am J Obstet Gynecol 2010; 203: 128.e1–12.
Goya, M, Pratcorona, L, Merced, C, et al. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet 2012; 379: 1800–6.
Hui, SY, Chor, CM, Lau, TK, Lao, TT, Leung, TY. Cerclage pessary for preventing preterm birth in women with a singleton pregnancy and a short cervix at 20 to 24 weeks: a randomized controlled trial. Am J Perinatol 2013; 30: 283–8.
Liem, S, Schuit, E, Hegeman, M, et al. Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial. Lancet 2013; 382: 1341–9.
Conde-Agudelo A, Romero R, Nicolaides KH. Cervical pessary to prevent preterm birth in asymptomatic high-risk women: a systematic review and meta-analysis. Am J Obstet Gynecol 2020; 223(1): 42–65.e2.
Alfirevic, Z, Owen, J, Carreras Moratonas, E, et al. Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix. Ultrasound Obstet Gynecol 2013; 41: 146–51.
Sandall, J, Soltani, H, Gates, S, Shennan, A, Devane, D. Midwife-led continuity models versus other models of care for childbearing women. Cochrane Database Syst Rev 2016; (4): CD004667. doi: 10.1002/14651858.CD004667.pub5.
Anotayanonth, S, Subhedar, NV, Neilson, JP, Harigopal, S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004;(4): CD004352.
King, JF, Flenady, V, Papatsonis, D, Dekker, G, Carbone, B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003; (1): CD002255.
Papatsonis, D, Flenady, V, Cole, S, Liley, H. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 2005; (3): CD004452.
Duckitt, K, Thornton, S, O’Donovan, OP, Dowswell, T. Nitric oxide donors for the treatment of preterm labour. Cochrane Database Syst Rev 2014; (5): CD002860.
King, JF, Flenady, V, Cole, S, Thornton, S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005; (2): CD001992.
Mills, EJ, Thorlund, K, Ioannidis, J. Demystifying trial networks and network meta-analysis. BMJ 2013; 346: f2914.
Haas, DM, Caldwell, DM, Kirkpatrick, P, Mcintosh, JJ, Welton, NJ. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 2012; 345: e6226
Mackeen, AD, Seibel-Seamon, J, Grimes-Dennis, J, Baxter, JK, Berghella, V. Tocolytics for preterm premature rupture of membranes. Cochrane Database Syst Rev 2011; (10): CD007062.
Naik Gaunekar, N, Raman, P, Bain, E, Crowther, CA. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev 2013; (10): CD004071.
Dodd, JM, Crowther, CA, Middleton, P. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database Syst Rev 2012; (12): CD003927.
Thornton, JG. Maintenance tocolysis. BJOG 2005; 112: 118–21.
Liggins, G Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969; 45: 515–23.
Crowley, P, Chalmers, I, Keirse, MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990; 97: 1125.
Roberts, D, Dalziel, S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; (3): CD004454.
Crowther, CA, McKinlay, CJ, Middleton, P, Harding, JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev 2015; (7): CD003935.
Dalziel, SR, Walker, NK, Parag, V, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: a 30-year follow-up of a randomised controlled trial. Lancet 2005; 365: 1856–62.
Althabe, F, Belizán, JM, McClure, EM, et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet 2015; 385: 629–39.
Back, SA, Han, BH, Luo, NL, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia–ischemia. The Journal of neuroscience 2002; 22: 455–63.
Haynes, RL, Folkerth, RD, Keefe, RJ, et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 2003; 62: 441–50.
McDonald, JW, Silverstein, FS, Johnston, MV. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett 1990; 109: 234–8.
Burd, I, Breen, K, Friedman, A, Chai, J, Elovitz, MA. Magnesium sulfate reduces inflammation-associated brain injury in fetal mice. Am J Obstet Gynecol 2010; 202: 292.e1–9.
Kuban, KC, Leviton, A, Pagano, M, et al. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol 1992; 7: 70–6.
Nelson, KB, Grether, JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995; 95: 263–9.
Crowther, CA, Hiller, JE, Doyle, LW, Hasslam, RR. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003; 290: 2669–76.
Chang, E Preterm birth and the role of neuroprotection. BMJ 2015; 350: g6661.
Marret, S, Marpeau, L, Zuban-Simunek, V, et al. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial. BJOG 2007; 114: 310–18.
Rouse, DJ, Hirtz, DG, Thom, E, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Eng J Med 2008; 359: 895905.
Doyle, LW, Crowther, CA, Middleton, P, Marret, S, Rouse, D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009; (1): CD004661.
Magee, L, Sawchuck, D, Synnes, A, Von Dadelszen, P. SOGC clinical practice guideline. Magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can 2011; 33: 516–29.
O’Shea, MT, Doyle, LW. Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective. Semin Neonatol 2001; 6: 293307
Fleiss, B, Parkington, HC, Coleman, HA, et al. Effect of maternal administration of allopregnanolone before birth asphyxia on neonatal hippocampal function in the spiny mouse. Brain Res 2012; 1433: 919.
Kenyon, SL, Taylor, DJ, Tarnow-Mordi, W; ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 2001; 357: 989–94.
Kenyon, S, Pike, K, Jones, DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008; 372: 1319–27.
Boyer, KM, Gotoff, SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. New Eng J Med 1986; 314: 1665–9.
Werner, EF, Savitz, DA, Janevic, TM, et al. Mode of delivery and neonatal outcomes in preterm, small-for-gestational-age newborns. Obstet Gynecol 2012; 120: 560–4.
Alfirevic, Z, Milan, SJ, Livio, S. Caesarean section versus vaginal delivery for preterm birth in singletons. The Cochrane Library 2012; (6): CD000078
Hannah, ME, Hannah, WJ, Hewson, SA, et al. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term Breech Trial Collaborative Group. Lancet 2000; 356: 1375–83.
Rosemann, G Vacuum extraction of premature infants. S Afr J Obstet Gynaecol 1969; 7: 1012.
Åberg, K, Norman, M, Ekéus, C. Preterm birth by vacuum extraction and neonatal outcome: a population-based cohort study. BMC Pregnancy Childbirth 2014; 14: 42.
Royal College of Obstetricians and Gynaecologists. Operative Vaginal Delivery. Green-top Guideline No. 26. London: RCOG, 2011. (accessed March 2017).
Rabe, H, Reynolds, G, Diaz-Rossello, J. Early versus delayed umbilical cord clamping in preterm infants. Cochrane Database Syst Rev 2004; (4): CD003248.

Send book to Kindle

To send this book to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

Available formats

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

Available formats